These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35757196)

  • 1. Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study.
    Xu L; Cui J; Li M; Wu Q; Liu M; Xu M; Shi G; Yin J; Yang J
    Diabetes Metab Syndr Obes; 2022; 15():1877-1884. PubMed ID: 35757196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum asprosin is correlated with diabetic nephropathy.
    Wang R; Lin P; Sun H; Hu W
    Diabetol Metab Syndr; 2021 May; 13(1):51. PubMed ID: 33933135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of asprosin and Nrg-4 with type 2 diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value.
    Zhong M; Tian X; Sun Q; Li L; Lu Y; Feng Z; Gao Y; Li S
    BMC Endocr Disord; 2023 Mar; 23(1):61. PubMed ID: 36915073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes.
    Deng X; Zhao L; Guo C; Yang L; Wang D; Li Y; Xia H; Wang C; Cai Z; Li L; Zhao Z; Yuan G
    Diabetes Metab Syndr Obes; 2020; 13():4341-4351. PubMed ID: 33223841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum myonectin concentrations in diabetic nephropathy patients.
    Zhang J; Hu W; Lin P; Wang R
    Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Dejenie TA; Abebe EC; Mengstie MA; Seid MA; Gebeyehu NA; Adella GA; Kassie GA; Gebrekidan AY; Gesese MM; Tegegne KD; Anley DT; Feleke SF; Zemene MA; Dessie AM; Moges N; Kebede YS; Bantie B; Adugna DG
    Front Endocrinol (Lausanne); 2023; 14():1124367. PubMed ID: 37082121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
    Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
    Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
    Zhang H; Hu W; Zhang G
    Int Urol Nephrol; 2020 Aug; 52(8):1517-1522. PubMed ID: 32458209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between glycaemic level and lipid profile with Albuminuria in Iraqi type 2 diabetes patients - A cross sectional study.
    Hassan Al-Bayati AA; Jawad Al-Khateeb SM
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S57-S62. PubMed ID: 35130220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentration of asprosin in new-onset type 2 diabetes.
    Naiemian S; Naeemipour M; Zarei M; Lari Najafi M; Gohari A; Behroozikhah MR; Heydari H; Miri M
    Diabetol Metab Syndr; 2020; 12():65. PubMed ID: 32714446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
    Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
    Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between serum cystatin-C levels and vibrating perception threshold in patients with 
Type 2 diabetes mellitus].
    Yan P; Zhang Z; Xu Y; Wan Q; Ma H; He J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 41(1):58-64. PubMed ID: 26819426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Serum Adropin Concentrations with Diabetic Nephropathy.
    Hu W; Chen L
    Mediators Inflamm; 2016; 2016():6038261. PubMed ID: 27546995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the triglyceride-glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross-sectional study.
    Liu L; Xia R; Song X; Zhang B; He W; Zhou X; Li S; Yuan G
    J Diabetes Investig; 2021 Apr; 12(4):557-565. PubMed ID: 33319507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sodium-glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus.
    Jiang A; Feng Z; Yuan L; Zhang Y; Li Q; She Y
    Diabetol Metab Syndr; 2021 Mar; 13(1):34. PubMed ID: 33766125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.
    Zhang L; Chen C; Zhou N; Fu Y; Cheng X
    Clin Chim Acta; 2019 Feb; 489():183-188. PubMed ID: 29104036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of dehydroepiandrosterone with diabetic nephropathy and its clinical value in early detection.
    Ma Y; Wang Q; Chen Y; Su J; Gao Q; Fan Y; Feng J; Liu M; He Q
    J Diabetes Investig; 2022 Oct; 13(10):1695-1702. PubMed ID: 35726691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of serum asprosin level with diabetic and non-diabetic retinopathy.
    Atlı H; Onalan E; Yakar B; Kaymaz T; Duzenci D; Karakulak K; Dönder E; Gürsu MF; Dayanan R
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2117-2123. PubMed ID: 35363361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.